ADPT earnings: real EPS beat/miss history, analyst consensus Buy, P/E -67.04. Updated 2026-07-23.
Adaptive Biotechnologies (ADPT) Research Hub
Adaptive Biotechnologies (ADPT) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 24.2 USD (-0.90%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -67.04, market cap 3.52B. This hub links to the full technical, earnings and options research available for ADPT.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 24.2 USD (-0.90%) |
| 52-week range | 16.43 USD – 26.58 USD |
| Trend regime | Range |
| 14-day RSI | 43.9 (Bearish) |
| Trailing P/E | -67.04 |
| Market cap | 3.52B |
| Dividend yield | 0.00% |
Available research for ADPT
Covered Call on ADPT: how it works, illustrative setup around the real 24.2 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ADPT: how it works, illustrative setup around the real 24.2 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ADPT: how it works, illustrative setup around the real 24.2 USD price, max profit/loss, breakeven and when to use it. Educational.
ADPT technical analysis: range, last 24.2 USD, RSI 43.9, 52w range 16.43 USD–26.58 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is ADPT in?
Adaptive Biotechnologies (ADPT) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ADPT in an uptrend or downtrend?
As of 2026-09-11, ADPT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ADPT's trailing P/E ratio?
ADPT's trailing P/E is -67.04, with a market cap of 3.52B. See the earnings research page for full valuation detail.